Caring for survivors of Hodgkin lymphoma: An evidence-based review of common late effects of HL treatment Review


Authors: Lin, X.; Corcoran, S.
Review Title: Caring for survivors of Hodgkin lymphoma: An evidence-based review of common late effects of HL treatment
Abstract: Hodgkin lymphoma (HL) is a highly curable cancer. Advances in diagnosis and treatment have resulted in excellent cure rates, producing an ever-increasing number of HL survivors who live decades beyond their initial cancer treatment. These survivors, however, are at risk for late effects secondary to the cancer treatments they received years earlier, most notably, subsequent primary cancers, cardiovascular disease, pulmonary toxicity, and endocrine dysfunction. Monitoring and managing such late treatment effects may significantly challenge survivors' long-term health care providers, who may need to take on increased survivorship care. For physicians and nurses working outside of oncology settings, who are increasingly called upon to collaborate with oncologists when caring for HL survivors, understanding the late treatment effects and potential risk factors facing this growing patient population is essential to the provision of comprehensive long-term care. The authors provide an overview of HL, review the most commonly encountered late adverse effects of treatment, and discuss current recommendations for survivor surveillance and screening. © 2019 Lippincott Williams and Wilkins. All rights reserved.
Keywords: treatment; oncology; late effects; hodgkin lymphoma
Journal Title: American Journal of Nursing
Volume: 119
Issue: 2
ISSN: 0002-936X
Publisher: Lippincott Williams & Wilkins  
Date Published: 2019-02-01
Start Page: 32
End Page: 41
Language: English
DOI: 10.1097/01.NAJ.0000553181.82330.d4
PUBMED: 30640208
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 1 March 2019 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Xin Lin
    7 Lin
Related MSK Work